These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34104846)

  • 1. Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.
    Cherian AM; Nair SV; Maniyal V; Menon D
    APL Bioeng; 2021 Jun; 5(2):021508. PubMed ID: 34104846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Stent Effectiveness with Nanofeatures.
    Bassous N; Cooke JP; Webster TJ
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):163-168. PubMed ID: 27826371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled benefits of nanotopography and titania surface chemistry in fostering endothelialization and reducing in-stent restenosis in coronary stents.
    Cherian AM; Joseph J; Nair MB; Nair SV; Vijayakumar M; Menon D
    Biomater Adv; 2022 Nov; 142():213149. PubMed ID: 36270158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress on Precise Regulation of Vascular Intimal Repair by a Surface Coating of Vascular Stent.
    Liu S; Zhi J; Li S; Song Z; Gong T; Pan C; Tang C; Xu N; Liu T
    Curr Drug Deliv; 2021; 18(7):862-873. PubMed ID: 33583378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology in development of next generation of stent and related medical devices: Current and future aspects.
    Islam P; Schaly S; Abosalha AK; Boyajian J; Thareja R; Ahmad W; Shum-Tim D; Prakash S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1941. PubMed ID: 38528392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.
    Sternberg K; Grabow N; Petersen S; Weitschies W; Harder C; Ince H; Kroemer HK; Schmitz KP
    Curr Pharm Biotechnol; 2013; 14(1):76-90. PubMed ID: 23092260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
    Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
    Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.
    Vanags LZ; Wong NKP; Nicholls SJ; Bursill CA
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1691-1701. PubMed ID: 29954755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary drug-eluting stents: from design optimization to newer strategies.
    Sun D; Zheng Y; Yin T; Tang C; Yu Q; Wang G
    J Biomed Mater Res A; 2014 May; 102(5):1625-40. PubMed ID: 23703913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.